ArticleEpidemiology and infection2017
Economics of zoonoses surveillance in a 'One Health' context: an assessment of Campylobacter surveillance in Switzerland.
Article in Epidemiology and infection, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
22 citing papers in PubMed, 1 synthesis or guideline pooled it.
- A systematic review of the methodological considerations in Campylobacter burden of disease studies.PLoS neglected tropical diseases · 2025Pooled it
- Mapping one health surveillance and networks for vector-borne disease prevention and control in Europe - A scoping review.One health (Amsterdam, Netherlands) · 2026Review
- Preharvest Control ofMicroorganisms · 2025Review
- Systematic review on evaluation tools applicable to One Health surveillance systems: A call for adapted methodology.One health (Amsterdam, Netherlands) · 2025Review
- One Health Economics approach to prevention and control of zoonotic and animal diseases - considerations for South Africa.One health outlook · 2025Article
- Current evidence of the economic value of One Health initiatives: A systematic literature review.One health (Amsterdam, Netherlands) · 2024Review
- Assessing the Adoption of One Health Approaches in National Plans to Combat Health Threats: The Pilot of a One Health Conceptual Framework in Armenia.Tropical medicine and infectious disease · 2024Article
- OH-EpiCap: a semi-quantitative tool for the evaluation of One Health epidemiological surveillance capacities and capabilities.Frontiers in public health · 2023Article
- China's One Health governance system: the framework and its application.Science in One Health · 2023Review
- How are large-scale One Health initiatives targeting infectious diseases and antimicrobial resistance evaluated? A scoping review.One health (Amsterdam, Netherlands) · 2022Article
- Social insights on the implementation of One Health in zoonosis prevention and control: a scoping review.Infectious diseases of poverty · 2022Article
- Editorial: Needs and potential application of One Health approach in the control of vector-borne and zoonotic infectious disease.Frontiers in microbiology · 2022Article
- A user-friendly decision support tool to assist one-health risk assessors.One health (Amsterdam, Netherlands) · 2021Article
- Review
- Quantitatively evaluating the cross-sectoral and One Health impact of interventions: A scoping review and case study of antimicrobial resistance.One health (Amsterdam, Netherlands) · 2021Article
- Evaluating the Integration of One Health in Surveillance Systems for Antimicrobial Use and Resistance: A Conceptual Framework.Frontiers in veterinary science · 2021Article
- Enhancing Preparedness for Arbovirus Infections with a One Health Approach: The Development and Implementation of Multisectoral Risk Assessment Exercises.BioMed research international · 2020Article
- A systematic review on integration mechanisms in human and animal health surveillance systems with a view to addressing global health security threats.One health outlook · 2020Review
- One health collaboration for a resilient health system in India: Learnings from global initiatives.One health (Amsterdam, Netherlands) · 2019Review
- Evidence needed for antimicrobial resistance surveillance systems.Bulletin of the World Health Organization · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cross-sectorial surveillance and general collaboration between the animal and the public health sectors are increasingly recognized as needed to better manage the impacts of zoonoses. From 2009, the Swiss established a Campylobacter mitigation system that includes human and poultry surveillance data-sharing within a multi-sectorial platform, in a 'One Health' approach. The objective of this study was to explore the economics of this cross-sectorial approach, including surveillance and triggered interventions. Costs and benefits of the One Health and of the uni-sectorial approach to Campylobacter surveillance were identified using an economic assessment framework developed earlier. Cost information of surveillance activities and interventions was gathered and disability-adjusted life years (DALYs) associated with the disease estimated for 2008 and 2013. In the first 5 years of this One Health approach to Campylobacter mitigation, surveillance contributed with information mainly used to perform risk assessments, monitor trends and shape research efforts on Campylobacter. There was an increase in costs associated with the mitigation activities following integration, due mainly to the allocation of additional resources to research and implementation of poultry surveillance. The overall burden of campylobacteriosis increased by 3·4-8·8% to 1751-2852 DALYs in 2013. In the timing of the analysis, added value associated with this cross-sectorial approach to surveillance of Campylobacter in the country was likely generated through non-measurable benefits such as intellectual capital and social capital.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.